Pricing Log in Create free account

Actinium Pharmaceuticals, Inc. (ATNM) vs Genenta Science S.p.A. Unsponsored ADR (GNTA)

Actinium Pharmaceuticals, Inc. and Genenta Science S.p.A. Unsponsored ADR are both Biotechnology companies. Actinium Pharmaceuticals, Inc. and Genenta Science S.p.A. Unsponsored ADR are of similar size ($33.3M and $32.3M). Across the 8 metrics below, Actinium Pharmaceuticals, Inc. leads on 4 and Genenta Science S.p.A. Unsponsored ADR on 4.

Valuation

Metric ATNM GNTA Biotechnology median
P/E 3.14 — 8.50
P/S 1.01 n/m 9.71
P/B 1.17 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales (0.03) n/m 9.21
Earnings yield 31.86% — (33.15%)
Free cash flow yield (65.52%) 0.00% (25.50%)

Profitability

Metric ATNM GNTA Biotechnology median
Gross margin 98.71% — 65.16%
Operating margin 27.20% — 0.00%
Net margin 32.18% — 0.00%
Free cash flow margin (66.16%) 0.00% 0.00%
Return on equity 45.86% 0.00% (56.36%)
Return on assets 21.92% 0.00% (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ATNM GNTA Biotechnology median
Revenue growth (TTM) 2,731.18% — 6.02%
EPS growth (last fiscal year) 14.17% 30.19% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ATNM GNTA Biotechnology median
Debt to equity 0.00 0.35 0.00
Current ratio 4.08 14.16 4.72
Net debt to EBITDA 1.35 3.12 0.96

Dividend

Metric ATNM GNTA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ATNM GNTA Biotechnology median
Market cap 33.32m 32.28m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack